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ABSTRACT 
Purpose: Quantitative gated single-photon emission computed tomography (SPECT) 
is known to have high accuracy and precision for measurement of the principal cardiac 
functional parameters. We hypothesised that normal values for EF and LV volumes may 
differ among nationalities, and that optimal threshold values specific to the study population 
are required. 
Methods: Among 4,670 consecutively registered patients for a J-ACCESS (Japanese 
investigation for prognosis based on gated SPECT) study from 117 hospitals, a total of 268 
patients (149 women, 119 men) were selected from those with no baseline cardiac diseases 
and with no cardiac events for a three-year period. A gated SPECT study was performed with 
99mTc tetrofosmin and analyzed with Cedars Sinai Medical Center's quantitative gated SPECT 
(QGS) software. The results of ejection fraction (EF), end-diastolic volume (EDV), 
end-systolic volume (ESV) and stroke volume (SV), and EDV, ESV and SV normalized by 
body surface area (EDVI, ESVI and SVI) were calculated and summarized to obtain normal 
limits. 
Results: EF for women and men was 74% ± 9 % and 63% ± 7% (p<0.0001). EDV, 
ESV and SV were significantly smaller in women than in men. Based on multiple regressions 
for linear models, the primary and secondary predictors of EF, EDVI, ESVI were gender and 
age. By stepwise multiple regression analysis, the statistically significant third predictor for 
EDV, ESV, SV and SVI was body weight. No colinearity was found between age and body 
weight. Important factors for the studied Japanese population included a high incidence of 
small hearts in women and the relatively advanced age of the population (the mean age ±SD 
was 64.1±10.0 years for women and 60.9±11.7 years for men). 
Conclusion: EF and volumes by gated SPECT with QGS were significantly affected by 
gender and ages, with body weight as the third predictor for volumes. Moreover, the normal 
limits were so specific for the population studied that standards appropriate for the study 
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should be utilized.  
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Introduction 
 
Left ventricular (LV) ejection fraction (EF) and ventricular volumes have been 
considered as one of the important factors for diagnosis and management of patients with 
cardiac diseases as well as prognostic values for future cardiac events [1-3]. Although 
echocardiography and gated blood-pool studies have been well-established methods for 
cardiology practice, gated myocardial perfusion SPECT has also been known to have high 
accuracy and precision for measuring principal cardiac functional parameters [1, 4, 5]. Some 
studies have reported the importance of generating normal limits for parameters of cardiac 
function using gated myocardial perfusion SPECT and their dependency on gender and, to 
some extent, age [6-8]. Determining normal values has also been considered important for the 
assessment of diastolic function with gated SPECT [9]. 
Nuclear studies with gated myocardial perfusion SPECT has become widely utilized 
in many countries because of its high accuracy and precision for LV EF and volumes [4, 
10-13]. In daily clinical practice, however, we have sometimes felt that the same standards 
could not be used universally, and previous studies based on a US or European population 
could not be readily applicable to Japanese population.  
We have been conducting a multi-center prognostic study (J-ACCESS; Japanese 
Assessment of Cardiac Event and Survival Study by Quantitative Gated SPECT) in 4670 
patients, and 117 hospitals have been involved. The study design has been described 
elsewhere [14]. Since this study was performed in a series of consecutive patients, 
near-normal subjects without specific evidence of cardiac disease were included; for the 
purpose of the present study, this permitted the selection of patients with no baseline cardiac 
diseases and absence of cardiac events during the preceding 3-year period. In other words, it 
was possible to apply strict criteria for normality or low likelihood of cardiac disease.  
Thus, we hypothesized that 1) a Japanese population has a different background and 
  5/27 
characteristics for LV EF and ventricular volumes, 2) The functional parameters may depend 
on gender and ages, but the mode of dependency may differ in this population. Finally, the 
normal limits obtained for the various ventricular functional parameters were compared with 
the results of previous US and European studies. 
 
Materials and Methods 
 
J-ACCESS study 
J-ACCESS aimed to establish a Japanese database for the diagnosis and treatment of 
ischemic heart disease, and patient registration was performed from October 1, 2001 to 
March 31, 2002. A total of 117 Japanese hospitals participated in this study. The patients 
were consecutively registered according to the following criteria: age > 20 years old, only 
those scheduled to take part in stress-rest gated SPECT study due to definite or possible 
ischemic heart disease, and availability of a written informed consent.  Exclusion criteria 
from the initial registration were patients with an onset of myocardial infarction or unstable 
angina pectoris within 3 months, valvular heart disease, idiopathic cardiomyopathy, severe 
arrhythmia, heart failure with class III or higher New York Heart Association (NYHA) 
classification, or severe liver or renal disorders. Among 4,670 registered patients, 41 patients 
were excluded because they did not fulfill the selection criteria, leaving 4,629 patients for 
follow-up investigations for three years. The gender and age distributions were 2,989 men 
(aged 21 to 90 years; average and SD, 64.9 ± 10.3) and 1,640 women (aged 20 to 93 years; 
67.2 ± 9.7). Since this registration was performed consecutively, patients with low risks for 
cardiac diseases were included. Age, gender, height, weight, subjective symptoms, history of 
present illness, medical history, risk factors, obesity and treatment before SPECT 
examination including revascularization and medication were surveyed. The registered 
patients underwent stress and rest myocardial perfusion SPECT with 99mTc tetrofosmin. 
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Gated SPECT was performed at rest, and standard QGS analysis (Cedars Sinai Medical 
Center, CA, US) was performed in each institute. As there was variation in reconstruction 
among the participating institutes, the inter-institution reproducibility of QGS results was 
assessed, as reported previously [15] and found to be good. The following examinations were 
conducted within two months before or after SPECT imaging: ECG at rest in 94% of the 
patients, stress ECG in 40%, echocardiography in 63%, chest X rays in 74%, coronary 
arteriography in 48%, and contrast left ventriculography in 37%. The findings were abnormal 
in 2,604 (60%) of the 4,367 patients who underwent ECG at rest. 
 
Patient selection 
Based on the patients' backgrounds, results of the stress and resting perfusion study 
and the cardiac events over a three-year period, the following criteria were used for selecting 
the patients appropriate for this study. 
1) No present or past history of cardiac disease was recorded. 
2) Absence of any of the following abnormalities or electrocardiographic (ECG) findings 
suggestive of ischaemia: left ventricular strain pattern, complete or incomplete bundle branch 
block, pacemaker implantation, atrial fibrillation, Q waves, QS patterns, inverted T waves, 
myocardial hypertrophy, sinus bradycardia or tachycardia, atrial flutter and atrioventricular 
block in the resting condition. Based on stress ECG records, patients with positive or 
borderline ECG changes and patients who had chest symptoms at peak exercise were also 
excluded. 
3) Based on the 20-segment segmentation and 5-point (0, normal; 4, absent uptake) scoring 
model, both the summed stress score and summed rest score were scored to be 3 or less [16, 
17]. 
4) During the follow-up of three years, no cardiac events were observed including 
percutaneous coronary intervention, angina pectoris and non-severe heart failure as soft 
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events, and cardiac death, non-cardiac death, myocardial infarction and severe heart failure as 
hard events.  
5) Regarding the underlying diseases, patients who had medications for hypertension or 
diabetes mellitus were excluded. However, patients with borderline hypertension or glucose 




Gated SPECT acquisition varied depending on the preference of the institutes. Since a 
total of 120 SPECT systems were used in the 117 institutes, adequacy of the following data 
was confirmed for 120 SPECT and computer systems. All institutes used a multi-detector 
camera: dual-detector with rectangular configuration (n=44), dual-detector with parallel 
configuration (n=31) and triple-detector (n=45) systems. The collimator type was 
high-resolution parallel (n=70), general purpose parallel (n=40) and other types (n=10). The 
matrix size of a frame was 64x64 (n=116) and 128x128 (n=4). The frame division per cardiac 
beat was 16 (n=38), 12 (n=11), 10 (n=4), 8 (n=64) and others (n=3). Acquisition time per 
view had a median of 30 seconds, a range of 20 to 60 seconds. Bad beat rejection for 
arrhythmia was performed in 88 of 120 systems. The acceptance window for data acquisition 
ranged from 10 to 60% with a median of 40%. Filtered back projection was used in 115 
institutes, and the remaining institutes used ordered subset expectation maximization 
algorithm. The reconstruction of SPECT slices was performed by a ramp filter (n=105), and 
the remaining institutes by a Shepp-Logan filter. A Butterworth filter was used in 116 
institutes as a pre-processing filter. Gender, age and body stature and weight were not found 
to vary according to the above acquisition conditions, thereby excluding technical bias. 
 
Data analysis and statistics 
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The parameters of EF (%), EDV (ml), ESV (ml) and SV (ml) were calculated in each 
institute by QGS software [4] and sent to the J-ACCESS office. Normalization by body 
surface area (BSA) was used to calculate EDV, ESV and SV indices (EDVI, ESVI and SVI: 
unit ml/m2). Statistics of the average, standard deviation (SD), median and percentile of 
distribution were calculated in each group. An analysis of variance for the mean was 
performed based on groups with gender, age and body weight. A multiple regression analysis 
with a linear model was performed with the standard and stepwise methods. Colinearity 




Based on the criteria for normal patients or low possibility of cardiac diseases, 268 
patients (5.8%) were selected out of 4,629 patients. Table 1 summarizes the gender-based 
patients demographics and parameters. The average and SD of the ages were 64.1 ± 10.0 
years for women and 60.9 ± 11.7 years for men (p=0.0172). The patients selected for this 
study were younger than the average age of J-ACCESS study (67.2 ± 9.7 for women and 64.9 
± 10.3 for men). The patient's height, weight and body surface area were smaller in women 
than in men. The average blood pressure at rest was 145/82 mmHg and 143/83 mmHg for 
women and men, showing high-normal or borderline hypertension reflecting the high-aged 
population. The heart rate and blood pressure at peak exercise did not differ significantly 
between genders. The changes in heart rate and blood pressure at pharmacological stress 
showed no gender differences.  
The value of EF was 74% ± 9% and 63 ± 7 % for women and men (p<0.0001). The 
EDV and ESV were smaller in women than in men. The EDVI was 39 ± 11 ml/m2 and 51 ± 
12 ml/m2, and ESVI was 11 ± 6 ml/m2 and 19 ± 7 ml/m2, respectively (p<0.0001 for both). 
Gated SPECT after stress showed similar gender differences. The resting SV was 43 ± 9 ml 
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vs. 55 ± 13 ml for women and men (p<0.0001), and the SVI was 28 ± 6 vs. 32 ± 7 ml/m2 for 
women and men (p<0.0001), respectively. When the resting SVI (y) was plotted versus the 
resting EDVI (x), the regression lines were y=0.483 x + 9.43 for women and y=0.489 x + 
7.08 for men, both showing similar slopes and a slightly higher intercept in women than in 
men. When the small heart was defined as ESV<20, the percentage of the small heart was 
74% and 13% for women and men, respectively (p<0.0001). 
Differences in age were summarized for three age groups of less than 60, 60 to 69 and 
70 or more (Table 2). In women, EF did not differ significantly among the three age groups. 
EDV, ESV, SV, EDVI, ESVI and SVI also did not differ significantly, although the 
percentage of patients with a small heart was higher in older female age groups (63% for <60 
year group, 77% for 60-69 year group, 81% for > 70% group; p=0.0227). In men, EF did not 
differ significantly among the three age groups, although the average value was slightly 
higher in older groups. EDV, ESV and SV decreased with age (p=0.0034, 0.0085 and 0.0211, 
respectively). ESVI showed smaller values in the higher age group (p= 0.0278), but EDVI 
and SVI did not show a significant difference. The percentage of patients with a small heart 
did not differ among male age groups, although it was slightly higher (28%) in the  >70 
group. The patients' height, weight and body weight were smaller in higher age groups.  
Multiple regression analysis was performed for EF, EDV, ESV, SV, EDVI, ESVI and 
SVI regarding the differences in gender, age and body weight as variables (Table 3). 
Significant variables for EF were gender and age based on a forward stepwise regression 
model. Gender, age and body weight were all significant variables for EDV, ESV and SV. 
When the possibility of colinearity was examined for variables of age and body weight, they 
were judged as independent indices for estimating volumes. When the ventricular volumes 
were normalized by body surface area, EDVI and ESVI showed gender and age as significant 
variables for multiple regression analysis. For all these models, gender was the primary 
predictor and age was the second predictor for LV volumes and volume indices. The variable 
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of body weight was the third weak predictor for LV volumes. When stepwise fit by all 
possible models was performed for EF, EDVI, ESVI and SVI, use of the 3 variables 
including body weight increased R2 only slightly and was not considered a significant 
additive value.  
Finally the effect of the number of frames per cardiac cycle was examined to check 
the dependency of the frame division on the gated SPECT results. A 16-frame division was 
used in 85 patients (32%) and an 8-frame division in 157 patients (59%). In women, EFs 
were 75%±9% (n=48) and 74±9% (n=89) for the 16-frame and 8-frame studies, respectively 
(p=n. s.). In men, EF with the 16-frame study was significantly higher than that with the 
8-frame study: 66±7% (n=37) vs. 62±7% (n=68) (p=0.006). As for ESV, the 16-frame and 
8-frame studies showed 17±8 ml vs. 16±10 ml in women (p=n. s.) and 32±14 ml vs. 33±14 
ml in men (p=n. s.). The distribution of the different frame groups did not differ significantly 
among the subgroups in terms of age, body weight, body surface area and genders based on 




Normal limits for gated SPECT and QGS software were determined based on the 
J-ACCESS database that has been compiled since 2001 [14]. The major conclusion of this 
study was that normal values for EF and LV volumes were significantly influenced by gender, 
and subsequently by age and body weight. The normal values for female patients showed a 
higher EF and a lower volumes in comparison to non-Japanese studies, and body weight was 
an important factor when LV volumes were not corrected by body surface area. The results 
suggested the importance of standards specific for each population.  
 
Characteristics of Japanese population 
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This study was performed from consecutive SPECT studies, and thus it reflects the 
daily nuclear medicine practice in Japan. When considering the average age of the subjects 
selected for the normal limits, the mean age indicated for nuclear cardiology seemed to be 5 
to 9 years higher in our study compared with those of previous studies conducted in the US 
and Europe. The subgroups of <60 years, 60-69 years and >70 years were used because the 
mode of age distribution was in the sixties in our study.  According to the report from the 
Ministry and of Health and Welfare of Japan, the life expectancy of a newborn in Japan in 
2004 was 78.36 and 85.33 years old for males and females, respectively. In 65 year olds, 
cardiac disease was the cause of 14.83% of deaths among men and 19.67% among women, 
while in 80 year olds it was the cause of 15.79% of deaths among men and 20.63% among 
women. The cause of death from cardiac disease was the second highest following the 
malignant neoplasm, and the importance of cardiac studies should be emphasized.  Another 
characteristic of this population was the frequency of patients with a small heart. Akincioglu 
et al. has excluded patients with a small heart defined as ESV <20 ml, because the main 
purpose was the evaluation of diastolic phase in their study [9]. It has been known that the 
values determined by QGS were less accurate for calculating small left ventricular volumes 
[11, 18-20]. At first we intended to exclude the small-heart patients, but we decided to 
include all of them because the percentage of subjects with a small heart was unexpectedly 
high in our study population, as high as ~80% for normal female patients particularly in 
patients in older age groups. Thus this study reflected the actual situation when we performed 
gated SPECT in Japan, and a similar situation might be applicable for other population in the 
East Asia. 
 
Dependency on gender 
Gender-specific differences have been described in previous studies with gated 
SPECT [6-9] as well as a larger scale MRI study in a probability-based Dallas heart study 
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[21]. Even after normalization of EF and volumes by body surface area, the difference 
between men and women was significantly different, implying dependency on an intrinsic 
physiologic difference between genders. Women had relatively small EDV, ESV and higher 
EF than men. Since heart rate was not different between genders, SVI should be similar for 
given EDVI to maintain comparable cardiac index (output per body surface area). The 
present study showed lower mean SV and SVI in women than in men, but the SVI for a given 
EDVI was found to be similar or rather slightly higher in women than in men. This EDV-SV 
relationship was also noted by an MRI study [21], and gated SPECT data also seemed to 
support the observation. In addition, the mean BSA for men in our study was approximately 
the same as the mean BSA for women in the European study [8]. However, EF was still 
higher in European women than in Japanese men. This finding appears to add further 
evidence that  the higher EF is related to a female gender and not just the small body and 
heart size. 
 
Dependency of age 
Age-related differences were found in men but not in women in the three age groups 
in this study. De Bondt et al. found differences in EF or volumetric parameters between the 
different age groups only in women of the >65 year age group who had significantly higher 
EF and significantly lower volumes [8]. Rozanski et al. found that the age correlated only 
weakly with LVEF and did not correlate with LV volume [6]. The age-related characteristics 
differed among studies, although the statistical significance was only weak in each study. The 
age-related differences might have been related to patient populations.  Multiple regression 
analysis in the present study showed age to be an important contributing factor for EF, EDV, 
ESV and SV for both genders, but it was a significant variable only in men; this indicates age 
to be a secondary factor. 
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Dependency on body weight 
Body weight was considered as the third factor for determining the LV volume as 
shown by the multiple regression analysis. However, after normalization by body surface area, 
weight was not selected as the significant determinant except for SV and SVI. Since women 
had lower body weight and the aged groups had lower body weight in our study, we 
suspected colinearity of gender and ages to body weight. But statistical analysis showed that 
colinearity was not significant between body weight and other variables. Thus use of volume 
index in the unit of ml/m2 is recommended rather than volume itself. When the parameters of 
EDV and ESV are directly used in a study, the effect of body weight should be kept in mind 
and its distribution should be confirmed among groups. 
 
Importance of population-specific standards 
This study demonstrated the importance of normal values for specific nationalities or 
races, or more strictly speaking, standards specific to each individual study should be used. 
Since the backgrounds of patients referred to nuclear cardiology studies may vary between 
races, caution should be observed when results from other countries are applied. Table 4 
shows the variability of normal EF, EDV and ESV, etc. from several studies we have 
mentioned in this discussion. The average age for gated SPECT was the highest in Japan, 
showing 64 ± 10 years and more than 10 years higher than the US studies [6-8]. When 
mean-2SD was used for normal lower limits, borderline EFs by Rozanski [6], Ababneh [7], 
De Bondt [8] and our data were 49%, 51%, 48% and 56% for women, and 41%, 48%, 47% 
and 49% for men, respectively. The higher borderlines (average +2SD) of EDV were 106, 91, 
121 and 93 ml for women, and 157, 118, 156 and 132 ml for men, respectively. Similarly, the 
upper borderlines of ESV were 47, 41, 55 and 37 ml for women, and 78, 55, 72 and 59 ml for 
men. Hence, the Japanese population showed the highest EF and the lower EDV and ESV as 
threshold values for abnormality.  
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The differences in EF and volumes for various nationalities are probably dependent 
on combinations of body weight, age and patient background rather than being specific to 
ethnicity per se. Taking these factors into account, however, the present study demonstrated 
the requirement for population-specific standards. 
 
Effect of technical issues 
When gated SPECT was analyzed with QGS software, one of the most important 
issues was underestimation of LV volumes in small heart patients. Our previous 
mathematical model showed non-linear underestimation of small volumes and pediatric 
studies, and was affected by acquisition conditions and processing parameters [4, 18]. This 
underestimation could not be readily corrected by a simple correction formula.  
Another factor was inconsistency of the acquisition protocol in 117 hospitals: 
including 8-16 frames per cardiac cycle, 360 or 180-degree rotations, heart-rate acceptance 
windows for data acquisition, etc. This study demonstrated that a 16-frame gated study 
resulted in approximately a 4% higher EF only in men compared with an 8-frame study. 
However, even if several possible combinations had been existed for acquisition and 
processing, we decided to disregard this if there was no bias for specific gender, age and body 
weight. Ababneh et al. compared EF, EDV and ESV obtained using 201Tl and 99mTc-sestamibi 
in patients with normal exercise tolerance and no wall motion abnormalities, and found no 
significant difference between the tracers. They also found no differences between 
180-degree and 360-degree rotations. Relatively low variability or acceptable precision by 
this J-ACCESS study was demonstrated by the study of the inter-institution preference based 
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 The normal limits were examined based on the J-ACCESS database with 268 of 4670 
patients registered for the multicenter study. The parameters of gender and age were 
important determinants for EF and LV volumes. Body weight was the third predictor when 
the volume was not normalized by body surface area. Higher ages and frequency of small 
heart were characteristics of our study group, and the importance of population-specific 
standards should be emphasized. 
 
Acknowledgement: We thank many physicians and technologists in the 117 hospitals 
participating in the J-ACCESS study for their cooperation. This work was mainly supported 
by grants from the Japan Cardiovascular Research Foundation, and partly by a Grants-in-Aid 
for Scientific Research in Japan for preparation of the manuscript.




1. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. 
ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide 
imaging--executive summary: a report of the American College of 
Cardiology/American Heart Association Task Force on Practice Guidelines 
(ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of 
Cardiac Radionuclide Imaging). Circulation 2003;108(11):1404-1418. 
2. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, et al. 
ACC/AHA 2002 Guideline Update for Exercise Testing: Summary Article A Report 
of the American College of Cardiology/American Heart Association Task Force on 
Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). 
Circulation 2002;1061883-1892. 
3. Tamaki N. Guidelines for Clinical Use of Cardiac Nuclear Medicine (JCS 2005). 
Circulation  Journal 2005;69 Suppl.  IV1125-1202. 
4. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic 
quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl 
Med 1995;36(11):2138-2147. 
5. Achtert AD, King MA, Dahlberg ST, Pretorius PH, LaCroix KJ, Tsui BM. An 
investigation of the estimation of ejection fractions and cardiac volumes by a 
quantitative gated SPECT software package in simulated gated SPECT images. J Nucl 
Cardiol 1998;5(2):144-152. 
6. Rozanski A, Nichols K, Yao SS, Malholtra S, Cohen R, DePuey EG. Development 
and application of normal limits for left ventricular ejection fraction and volume 
measurements from 99mTc-sestamibi myocardial perfusion gates SPECT. J Nucl Med 
2000;41(9):1445-1450. 
  17/27 
7. Ababneh AA, Sciacca RR, Kim B, Bergmann SR. Normal limits for left ventricular 
ejection fraction and volumes estimated with gated myocardial perfusion imaging in 
patients with normal exercise test results: influence of tracer, gender, and acquisition 
camera. J Nucl Cardiol 2000;7(6):661-668. 
8. De Bondt P, Van de Wiele C, De Sutter J, De Winter F, De Backer G, Dierckx RA. 
Age- and gender-specific differences in left ventricular cardiac function and volumes 
determined by gated SPET. Eur J Nucl Med 2001;28(5):620-624. 
9. Akincioglu C, Berman DS, Nishina H, Kavanagh PB, Slomka PJ, Abidov A, et al. 
Assessment of diastolic function using 16-frame 99mTc-sestamibi gated myocardial 
perfusion SPECT: normal values. J Nucl Med 2005;46(7):1102-1108. 
10. Nichols K, Tamis J, DePuey EG, Mieres J, Malhotra S, Rozanski A. Relationship of 
gated SPECT ventricular function parameters to angiographic measurements. J Nucl 
Cardiol 1998;5(3):295-303. 
11. Vallejo E, Dione DP, Sinusas AJ, Wackers FJ. Assessment of left ventricular ejection 
fraction with quantitative gated SPECT: accuracy and correlation with first-pass 
radionuclide angiography. J Nucl Cardiol 2000;7(5):461-470. 
12. Thorley PJ, Smith JM. Repeatability of left ventricular ejection fraction and volume 
measurement for 99mTc-tetrofosmin gated single photon emission computed 
tomography (SPECT). Nucl Med Commun 2005;26(4):345-349. 
13. Nakajima K, Higuchi T, Taki J, Kawano M, Tonami N. Accuracy of ventricular 
volume and ejection fraction measured by gated myocardial SPECT: comparison of 4 
software programs. J Nucl Med 2001;42(10):1571-1578. 
14. Kusuoka H, Nishimura S, Yamashina A, Nakajima K, Nishimura T. Surveillance 
study for creating the national clinical database related to ECG-gated myocardial 
perfusion SPECT of ischemic heart disease: J-ACCESS study design. Ann Nucl Med 
2006;20(3):195-202. 
  18/27 
15. Nakajima K, Nishimura T. Inter-institution preference-based variability of ejection 
fraction and volumes using quantitative gated SPECT with 99mTc-tetrofosmin: a 
multicentre study involving 106 hospitals. Eur J Nucl Med Mol Imaging 
2006;33(2):127-133. 
16. Berman DS, Abidov A, Kang X, Hayes SW, Friedman JD, Sciammarella MG, et al. 
Prognostic validation of a 17-segment score derived from a 20-segment score for 
myocardial perfusion SPECT interpretation. J Nucl Cardiol 2004;11(4):414-423. 
17. Sharir T, Germano G, Kang X, Lewin HC, Miranda R, Cohen I, et al. Prediction of 
myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: 
risk stratification by the amount of stress-induced ischemia and the poststress ejection 
fraction. J Nucl Med 2001;42(6):831-837. 
18. Nakajima K, Taki J, Higuchi T, Kawano M, Taniguchi M, Maruhashi K, et al. Gated 
SPET quantification of small hearts: mathematical simulation and clinical application. 
Eur J Nucl Med 2000;27(9):1372-1379. 
19. Khalil MM, Elgazzar A, Khalil W, Omar A, Ziada G. Assessment of left ventricular 
ejection fraction by four different methods using 99mTc tetrofosmin gated SPECT in 
patients with small hearts: correlation with gated blood pool. Nucl Med Commun 
2005;26(10):885-893. 
20. Hambye AS, Vervaet A, Dobbeleir A. Variability of left ventricular ejection fraction 
and volumes with quantitative gated SPECT: influence of algorithm, pixel size and 
reconstruction parameters in small and normal-sized hearts. Eur J Nucl Med Mol 
Imaging 2004;31(12):1606-1613. 
21. Chung AK, Das SR, Leonard D, Peshock RM, Kazi F, Abdullah SM, et al. Women 
have higher left ventricular ejection fractions than men independent of differences in 
left ventricular volume: the Dallas Heart Study. Circulation 2006;113(12):1597-1604. 
 
  19/27 
 
  20/27 
 
Table 1. Parameters of gated SPECT with respect to gender difference  
    Gender   p value 
  Women Men  
    Mean±SD Mean±SD   
Number of patients 149 119  
Age   64.1±10.0 60.9±11.7 0.017 
 Range 30-85 21-82  
Stature    
 BSA (m2) 1.49±0.13 1.72±0.15 <0.0001 
 Height (cm) 152.3±5.8 165.8±7.2 <0.0001 
 Weight (kg) 53.9±8.8 65.1±10.2 <0.0001 
HR and BP  at rest    
 HR (/min) 73.7±11.3 71.8±13.3 n. s. 
 SP (mmHg) 145±21.6 142.8±21.4 n. s. 
 DP (mmHg) 82.3±14.5 82.5±13.2 n. s. 
HR and BP at peak exercise   
 Number 110 93  
 HR (/min) 133.2±20.8 133.6±19.7 n. s. 
 SP (mmHg) 197.6±28.6 204.2±28.9 n. s. 
 DP (mmHg) 97.1±19.4 97.7±19.7 n. s. 
HR and BP at pharmacological stress   
 Number 39 26  
 HR (/min) 87.8±16.4 85.6±19.2 n. s. 
 SP (mmHg) 134.2±18.9 137.5±23.8 n. s. 
 DP (mmHg) 71.0±14.7 73.3±17.0 n. s. 
Resting condition    
 EF (%) 73.7±9.3 63.1±7.2 <0.0001 
 EDV (ml) 59.0±16.8 87.9±22.8 <0.0001 
 ESV (ml) 16.5±9.9 32.9±13.4 <0.0001 
 SV (ml) 42.5±9.4 54.9±12.6 <0.0001 
 EDVI (ml/m2) 39.3±10.7 51.1±11.8 <0.0001 
 ESVI (ml/m2) 10.9±6.4 19.0±7.1 <0.0001 
 SVI (ml/m2) 28.4±6.1 32.1±6.9 <0.0001 
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Post-stress condition    
 Number 101 75  
 EF (%) 72.4±9.2 63.3±6.6 <0.0001 
 EDV (ml) 57.6±17.9 83.9±22.5 <0.0001 
 ESV (ml) 16.8±10.6 31.1±12.0 <0.0001 
 SV (ml) 40.8±9.7 52.9±13.2 <0.0001 
 EDVI (ml/m2) 38.6±11.6 48.3±11.4 <0.0001 
 ESVI (ml/m2) 11.2±7.1 17.8±5.8 <0.0001 
 SVI (ml/m2) 27.3±6.2 30.5±7.3 0.002 
Small heart (ESV<20 ml) 74% 13% <0.0001 
BSA, body surface area; HR, heart rate;    
BP, blood pressure; SP, systolic pressure; DP, diastolic pressure;  
EF, ejection fraction; EDV, end-diastolic volume; ESV, end-systolic volume; SV, stroke 
volume; 
EDVI, end-diastolic volume index; ESVI, end-systolic volume index; SVI, stroke volume 
index 
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Table 2. Age-related difference of EF, volumes, volume indices  
Parameters Age groups (years old)     
  <60 60-69 >=70 ANOVA p 
Women     
Number 41 60 48  
HR (/min) 76±12 75±12 71±10 n. s. 
SP (mmHg) 141±21 146±21 148±23 n. s. 
DP (mmHg) 83±13 85±13 79±16 n. s. 
EF (%) 73.0±10.2 74.6±9.5 73.0±8.3 n. s. 
EDV (ml) 63.1±19.3 58.0±13.8 56.8±17.6 n. s. 
ESV (ml) 18.4±11.4 15.4±8.4 16.2±10.0 n. s. 
SV (ml) 44.7±9.9 42.6±8.8 40.6±9.4 n. s. 
EDVI (ml/m2) 41.4±11.5 38.1±8.3 39.0±12.3 n. s. 
ESVI (ml/m2) 12.0±7.1 10.0±5.3 11.1±6.9 n. s. 
SVI (ml/m2) 29.4±5.9 28.1±5.7 27.8±6.7 n. s. 
Small heart (%) * 63% 77% 81% 0.023 
Height (cm) 156.4±5.8 152.2±4.6 148.9±4.9 <0.0001 
Weight (kg) 53.8±8.3 55.1±9.3 52.6±8.5 n. s. 
BSA (m2) 1.52±0.12 1.50±0.12 1.45±0.12 0.021 
Men     
Number 49 41 29  
HR (/min) 76±14 68±12 70±12 0.012 
SP (mmHg) 140±19 140±18 151±27 0.046 
DP (mmHg) 85±13 80±14 81±12 n. s. 
EF (%) 62.1±7.7 63.0±6.2 65.0±7.8 n. s. 
EDV (ml) 95.4±23.6 85.9±22.3 78.1±17.5 0.003 
ESV (ml) 36.9±15.0 32.0±12.6 27.5±9.2 0.009 
SV (ml) 58.4±12.3 53.9±12.9 50.5±11.5 0.021 
EDVI (ml/m2) 53.9±11.3 50.4±13.1 47.3±9.6 n. s. 
ESVI (ml/m2) 20.8±7.5 18.8±7.2 16.2±5.2 0.028 
SVI (ml/m2) 33.1±6.4 31.6±7.6 31.0±6.3 n. s.  
Small heart (%) * 10% 7% 28% n. s. 
Height (cm) 168.6±7.8 165.0±6.3 162.1±5.6 0.0005 
Weight (kg) 67.9±10.6 64.5±9.9 61.1±8.8 0.018 
BSA (m2) 1.77±0.16 1.70±0.14 1.64±0.13 0.002 
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*ESV<20 ml     
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Table 3.      
Multiple regression analysis  for EF, volumes and volume indices  
Parameters 
Variables and regression 














R2=0.30    2 
 Gender(women-men) -4.69 <0.0001 0.28  
 Age 0.13 0.004 0.30  
 Body weight -0.070 n. s.  0.31  
      
EDV 
R2=0.47, adjusted 
R2=0.46    3 
 Gender(women-men) -11.35 <0.0001 0.36  
 Age -0.55 <0.0001 0.44  
 Body weight 0.45 0.0002 0.47  
      
ESV 
R2=0.44, adjusted 
R2=0.43    3 
 Gender(women-men) -6.60 <0.0001 0.34  
 Age -0.32 <0.0001 0.42  
 Body weight 0.22 0.003 0.44  
      
SV 
R2=0.34, adjusted 
R2=0.33    3 
 Gender(women-men) -4.75 <0.0001 0.26  
 Age -0.23 <0.0001 0.31  
 Body weight 0.23 0.001 0.34  
      
EDVI 
R2=0.27, adjusted 
R2=0.26    2 
 Gender(women-men) -6.05 <0.0001 0.22  
 Age -0.27 0.0001 0.26  
 Body weight -0.11 n. s. 0.27  
      
ESVI 
R2=0.32, adjusted 
R2=0.31    2 
 Gender(women-men) -3.78 <0.0001 0.27  
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 Age -0.16 0.017 0.32  
 Body weight 0.0032 n. s. 0.32  
      
SVI 
R2=0.12, adjusted 
R2=0.11    3 
 Gender(women-men) -2.27 <0.0001 0.075  
 Age -0.11 0.017 0.095  
  Body weight -0.11 0.010 0.12   
R2 and adjusted R2  are given by three variables with gender, age and body weight 
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Women      
 n 100 124 59 19 149 
 Age (years old) 52±13* 60±12** 59±12 52±12 64±10 
 LVEF (%) 67±9 67±8 66±9 67±6 74±9 
 LVEDV (ml) 62±22 57±17 75±23 91±17 59±17 




ESV (ml) 41 38 48 60 42 
 
LVEDVI 
(ml/m2) 35±11 32±8 43±11  39±11 




ESVI (ml/m2) 23 22 27  28 
 BSA (m2) 1.75±0.20  1.7±0.2  1.49±0.13 
Men       
 n 78 116 43 71 119 
 Age (years old) 52±13* 60±12** 56±13 53±11 61±12 
 LVEF (%) 59±9 62±7 59±6 63±5 63±7 
 LVEDV (ml) 95±31 74±22 106±25 110±20 88±22 




ESV (ml) 55 45 62 69 55 
 
LVEDVI 
(ml/m2) 48±14 38±9 54±14  51±12 




ESVI (ml/m2) 28 23 31  32 
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  BSA (m2) 1.97±0.21   2.0±0.2   1.72±0.15 
Methods      



















(n=1513)       
       
 
 
